News for 'Emergency Use Authorisation'

Kumbh: 2 crore take Maghi Purnima dip; kalpvasis to return

Kumbh: 2 crore take Maghi Purnima dip; kalpvasis to return

Rediff.com12 Feb 2025

Amid heightened security measures, more than two crore devotees took a dip in the Sangam till 6 pm on Wednesday on the occasion of Maghi Purnima during the ongoing Maha Kumbh Mela in Prayagraj.

HEX20 Elevates India With Nila Launch

HEX20 Elevates India With Nila Launch

Rediff.com7 Apr 2025

'The launch of Nila, our very first satellite was very emotional as well as nerve wracking. We tried to calm ourselves by cracking some poor jokes!'

Brazil scraps Covaxin's EUA application

Brazil scraps Covaxin's EUA application

Rediff.com27 Jul 2021

The Brazilian health regulator's decision comes after the vaccine maker informed the South American country about the termination of its pact with its partners in that country.

DCGI approves mRNA Covid jab for 18 yrs & above; Covovax for 7-11 yrs

DCGI approves mRNA Covid jab for 18 yrs & above; Covovax for 7-11 yrs

Rediff.com28 Jun 2022

The DCGI's nod came after the subject expert committee on COVID-19 of the CSDCO last week recommended granting emergency use authorisation to Covovax for the age group of 7 to 11 years.

Covishield, Covaxin get regular market approval

Covishield, Covaxin get regular market approval

Rediff.com27 Jan 2022

Under the conditions, the firms shall submit data of ongoing clinical trials and the vaccines to be supplied for programmatic setting.Adverse event following immunisation will continue to be monitored.

What If China, America Make Up?

What If China, America Make Up?

Rediff.com13 Feb 2025

Trump spoke approvingly of his recent telephone conversation with Xi Jinping. This could indicate the possibility of America and China reaching some level of tactical accommodation, which would not be good news for India, points out Ambassador Shyam Saran, a former foreign secretary.

Should Govt Continue Covid Vax Drive?

Should Govt Continue Covid Vax Drive?

Rediff.com20 May 2024

India has covered enough population with vaccine and infection, but protein vaccines should remain available on payment basis for elderly and those with comorbidities.

WHO meet next week to discuss Covaxin approval

WHO meet next week to discuss Covaxin approval

Rediff.com18 Oct 2021

The World Health Organisation's technical advisory group will meet on October 26 to consider the Emergency Use Listing (EUL) of Covaxin, a vaccine developed by Hyderabad-based Bharat Biotech protecting against COVID-19, the global health agency's chief scientist said.

US gives full approval to Pfizer Covid vaccine

US gives full approval to Pfizer Covid vaccine

Rediff.com23 Aug 2021

More than 200 million Pfizer doses have been administered in the US, and hundreds of millions more worldwide, since December.

Nod for Covid vaccine in next few days: Serum Institute's Poonawalla

Nod for Covid vaccine in next few days: Serum Institute's Poonawalla

Rediff.com29 Dec 2020

The Serum Institute of India has stockpiled 40 mn-50 mn doses and is adding more every week. Most of these will come to India.

Sales of Biocon's itolizumab surge as phase-4 clinical trials begin

Sales of Biocon's itolizumab surge as phase-4 clinical trials begin

Rediff.com6 Oct 2020

In India, itolizumab, known by the brand name Alzumab, has been priced at Rs 8,000 per vial. Most patients require four vials for Covid-19 treatment, taking the cost of the therapy to Rs 32,000.

Will Trump 2.0 See More US Oil To India?

Will Trump 2.0 See More US Oil To India?

Rediff.com22 Jan 2025

'The US is strongly placed to expand its crude supplies to India.'

'Unprecedented vaccine trial in India'

'Unprecedented vaccine trial in India'

Rediff.com23 Dec 2020

Bharat Biotech recruited 13,000 participants for the Phase-3 clinical trial of Covaxin. This is one of the largest efficacy trials held in the country.

1st lot of Sputnik V vaccine likely in India by May end

1st lot of Sputnik V vaccine likely in India by May end

Rediff.com27 Apr 2021

Once available, Sputnik V will be the third vaccine to be used in India against coronavirus.

Why early applicant Pfizer's Covid vaccine is delayed

Why early applicant Pfizer's Covid vaccine is delayed

Rediff.com19 Jan 2021

Pfizer sought to participate in the Subject Expert Committee consultations towards an emergency use authorisation for its Covid-19 vaccine. However, the company representatives have been unable to participate in the meetings because of extremely short notices of a few hours or less and time-zone limitations.

Serum Institute seeks nod to manufacture Sputnik V vaccine

Serum Institute seeks nod to manufacture Sputnik V vaccine

Rediff.com3 Jun 2021

Russia's Sputnik V vaccine is currently being manufactured in India by Dr Reddy's Laboratories.

Zydus Cadila seeks nod for its COVID vaccine for 12 years, above

Zydus Cadila seeks nod for its COVID vaccine for 12 years, above

Rediff.com1 Jul 2021

Drug firm Zydus Cadila on Thursday said it has applied for emergency use authorisation (EUA) with the Indian drug regulator for its three-dose COVID-19 vaccine ZyCoV-D, and plans to manufacture 10-12 crore doses annually.

US approves Johnson & Johnson's Covid vaccine

US approves Johnson & Johnson's Covid vaccine

Rediff.com28 Feb 2021

The Johnson and Johnson vaccine, which works with one dose instead of two, got approval on Saturday, the third vaccine cleared in the country after emergency use authorisation (EUA) was given to two-dose shots from Pfizer and Moderna in December last year.

Bharat Biotech making single-dose intranasal Covid vaccine

Bharat Biotech making single-dose intranasal Covid vaccine

Rediff.com21 Apr 2021

Efforts are being ramped up for massive production of vaccines and make them available in the shortest possible time, a top government official said on Wednesday, stressing that India currently has a promising pipeline of four-five Covid-19 vaccine candidates, while three have already been approved for emergency use.

Vaccine will be available to all

Vaccine will be available to all

Rediff.com17 Dec 2020

The vaccine would be first made available to the vulnerable population and eventually, it would be available in the private market for all.

Pfizer seeks approval in India for Covid vaccine

Pfizer seeks approval in India for Covid vaccine

Rediff.com6 Dec 2020

'Pfizer India has submitted an application on December 4 to the DCGI seeking emergency use authorization for its COVID-19 vaccine in India'

Govt SOPs on treating Covid in kids prohibits use of remdesivir

Govt SOPs on treating Covid in kids prohibits use of remdesivir

Rediff.com10 Jun 2021

The government has come out with comprehensive guidelines for the management of COVID-19 among children in which Remdesivir has not been recommended and rational use of HRCT imaging has been suggested.

Bangladesh foreign secy meets Indian envoy over border tensions

Bangladesh foreign secy meets Indian envoy over border tensions

Rediff.com12 Jan 2025

Bangladesh has summoned the Indian High Commissioner in Dhaka over border tensions, accusing India of violating a bilateral agreement by constructing fences at five locations along the Indo-Bangla border. The development comes after Bangladesh officials alleged that India had halted construction of barbed wire fencing due to strong opposition from the Border Guard Bangladesh and local residents.

Coldplay, Diljit tickets: ED lodges money laundering case

Coldplay, Diljit tickets: ED lodges money laundering case

Rediff.com26 Oct 2024

The Enforcement Directorate (ED) on Saturday said it has detected alleged irregularities after it conducted raids in a money laundering case to probe 'black marketing' of tickets for two 'highly anticipated' music concerts by British rock band Coldplay and actor-singer Diljit Dosanjh.

Expert panel bats for Covovax as Covid booster jab for adults

Expert panel bats for Covovax as Covid booster jab for adults

Rediff.com12 Jan 2023

It has been approved by the European Medicines Agency for conditional marketing authorisation.

COVID-19: Remdesivir will be available from next week

COVID-19: Remdesivir will be available from next week

Rediff.com4 May 2020

The EUA allows for Remdesivir to be distributed in the US and administered intravenously by health care providers, as appropriate, to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalised with severe condition.

Mandaviya meets Dr Reddy's Lab chief on Sputnik V production

Mandaviya meets Dr Reddy's Lab chief on Sputnik V production

Rediff.com5 Aug 2021

Dr Reddy's, which has tied up with Russian Direct Investment Fund for Sputnik V in India, soft launched the vaccine in India in May 2021, after receiving Emergency Use Authorisation in April 2021.

Biden, wife to receive Pfizer COVID-19 vaccine on Monday

Biden, wife to receive Pfizer COVID-19 vaccine on Monday

Rediff.com19 Dec 2020

Biden previously told Jake Tapper of CNN that he would be "happy to" take the COVID-19 vaccine once US infectious disease expert Anthony Fauci said it was safe and he would get the injection in a public setting to prove it.

WHO suspends Covaxin supply to UN agencies

WHO suspends Covaxin supply to UN agencies

Rediff.com3 Apr 2022

A statement issued by the WHO on Saturday said the suspension is in response to the outcomes of its post EUL (emergency use authorisation) inspection held between March 14-22, 2022 and the need to conduct process and facility upgrade to address recently identified GMP (good manufacturing practice) deficiencies.

US FDA warns against side effects of malaria drug

US FDA warns against side effects of malaria drug

Rediff.com25 Apr 2020

FDA said as of now it has issued an emergency use authorisation to allow hydroxychloroquine and chloroquine products donated to the Strategic National Stockpile to be distributed.

Sputnik V vaccine may be added to India's Covid armoury soon

Sputnik V vaccine may be added to India's Covid armoury soon

Rediff.com30 Mar 2021

'We expect to get the approval in the next few weeks,' says Deepak Sapra, CEO, API and pharmaceutical services, Dr Reddy's Laboratories (DRL).

Best Business Ideas Under Rs 1 Crore

Best Business Ideas Under Rs 1 Crore

Rediff.com10 Feb 2025

India's e-commerce market alone is projected to reach $200 billion by 2026, making it a prime industry for ambitious entrepreneurs, explains rediffGURU Harsh Bharwani.

Does India have enough vaccine reserves to combat another Covid wave?

Does India have enough vaccine reserves to combat another Covid wave?

Rediff.com27 Dec 2023

According to CoWIN data, only 73 vaccination centres are currently active in India, of which 32 are government-run.

8 vaccines, 4 treatments in India's COVID-19 arsenal

8 vaccines, 4 treatments in India's COVID-19 arsenal

Rediff.com28 Dec 2021

The Central Drugs Standard Control Organisation has granted restricted emergency use authorisation to two new vaccines and a drug for COVID-19, taking the number of preventives and treatments available in India to 12.

Explained: What USFDA full approval to Pfizer-BioNTech vaccine means

Explained: What USFDA full approval to Pfizer-BioNTech vaccine means

Rediff.com17 Sep 2021

Pfizer can show the FDA approval to the Indian regulator and present a case that based on whatever data submitted, the US regulator has granted a full marketing nod, says Sohini Das.

US sets new record with over 3,000 COVID deaths in 1 day

US sets new record with over 3,000 COVID deaths in 1 day

Rediff.com10 Dec 2020

The previous single-day record was on May 7 at 2,769 deaths.

COVID-19 vaccines likely to have longer shelf life

COVID-19 vaccines likely to have longer shelf life

Rediff.com14 Dec 2020

A longer shelf life is critical, given many makers have started manufacturing vaccines and stockpiling them, so as to make them available in the market immediately after approval, reports Sohini Das.

Govt fast-tracks approval for foreign-produced COVID vaccines

Govt fast-tracks approval for foreign-produced COVID vaccines

Rediff.com13 Apr 2021

The first 100 beneficiaries of such foreign vaccines shall be assessed for seven days for safety outcomes before it is rolled out for further immunisation programme within the country, the Union health ministry said.

50 million doses of Covaxin set to expire in 2023

50 million doses of Covaxin set to expire in 2023

Rediff.com6 Nov 2022

Nearly 50 million doses of Bharat Biotech's COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year as there are no takers owing to poor demand, company sources said.

US regulators recommend pause on J&J vaccine over rare blood clots

US regulators recommend pause on J&J vaccine over rare blood clots

Rediff.com13 Apr 2021

In a joint statement, the CDC and the FDA said they were investigating clots in six women in the days after vaccination, in combination with reduced platelet count.